Lung Point of Care Ultrasound to Guide Albumin Administration in Cirrhosis
NCT07072572 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 72
Last updated 2025-07-18
Summary
To guide the administration of intravenous albumin by lung ultrasound in decompensated cirrhosis.
Conditions
- Cirrhosis
- Cirrhosis Advanced
- Acute Kidney Injury
- Ascites
Interventions
- DRUG
-
Lower albumin dosage
A fixed dose of 35 grams of albumin on they one and day two.
Sponsors & Collaborators
-
Centro Medico Issemym
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-01
- Primary Completion
- 2023-12-14
- Completion
- 2024-11-14
Countries
- Mexico
Study Locations
More Related Trials
-
Phase Ib of Recombinant Human Albumin Injection
NCT04701697 ·Status: COMPLETED ·Phase: PHASE1
-
Study About Hepatic Toxins Kinetic and Evaluation of Organ Damage in Acute on Chronic Liver Failure (ACLF) Patients
NCT06837766 ·Status: RECRUITING
-
High Dose Albumin in Refractory Ascites
NCT05867602 ·Status: RECRUITING ·Phase: PHASE2
-
Body Composition Analysis in Cirrhotic Undergoing Paracentesis
NCT02022150 ·Status: UNKNOWN
-
Albumin Infusion in Inpatients With Decompensated Cirrhosis
NCT05719051 ·Status: UNKNOWN
-
Tolvaptan for Ascites in Cirrhotic Patients
NCT01292304 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Targeted And Response-Guided Albumin Therapy Versus Standard Medical Treatment In Outcomes Of Recurrent Ascites In Patients With Decompensated Cirrhosis.
NCT04679571 ·Status: UNKNOWN ·Phase: NA
-
The Influence of Paracentesis on Intra-abdominal Pressure and Kidney Function in Critically Ill Patients With Liver Cirrhosis and Ascites: an Observational Study
NCT01091233 ·Status: WITHDRAWN
-
PEriToneal Catheter Versus Repeated Paracentesis for Ascites in Cirrhosis
NCT03027635 ·Status: TERMINATED ·Phase: NA
-
TIPS With Coated Stents for Refractory Ascites in Patients With Cirrhosis
NCT00222014 ·Status: COMPLETED ·Phase: NA
-
Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites
NCT05056220 ·Status: RECRUITING ·Phase: PHASE3
-
Refractory Ascitis Diagnosis by the Study of Labelled Albumin Pharmacokinetics
NCT02818673 ·Status: UNKNOWN ·Phase: PHASE3
-
Effects of Long-Term Administration of Human Albumin in Participants With Decompensated Cirrhosis and Ascites
NCT03451292 ·Status: COMPLETED ·Phase: PHASE3
-
Human Albumin for the Treatment of Ascites in Patients With Hepatic Cirrhosis
NCT01288794 ·Status: COMPLETED ·Phase: PHASE4
-
The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrhosis
NCT07172035 ·Status: RECRUITING
-
Concordance Between Echocardiographic Assessment Performed in the Initial Phase of Decompensated Cirrhosis With Edema and Ascites by an Expert Intensive Care Physician and a Non-expert Gastroenterologist
NCT03650660 ·Status: TERMINATED
-
Initial Resuscitation for Acute Kidney Injury in Cirrhosis
NCT06525623 ·Status: RECRUITING ·Phase: NA
-
Transjugular Intrahepatic Portosystemic Shunts Improve Survival in Patients With Cirrhosis and Recurrent Ascites
NCT06196723 ·Status: COMPLETED
-
Effects of Maintaining Steady Albumin Levels (TAT 4) on Survival and Liver Related Complications in Cirrhosis With Ascites
NCT04058613 ·Status: UNKNOWN ·Phase: NA
-
A (M)Ulti-center, Prospective, (O)Pen Label, Uncontrolled Feasibility (S)Tudy to Assess the Safety and Effectiveness of an Automatic Low Flow (A)Scites (Alfa) Pump (I)n Patients With (C)Irrhosis and Refractory or Recurrent Ascites
NCT02400164 ·Status: COMPLETED ·Phase: NA
-
Prospective Evaluation of PleurX Drain for Treatment of Cirrhotic Refractory Ascites
NCT04569565 ·Status: COMPLETED ·Phase: NA
-
On Demand Versus Protocol-guided Renal Replacement Therapy for Management of Stage 3 Acute Kidney Injury in Patients With Cirrhosis
NCT02937935 ·Status: UNKNOWN ·Phase: NA
-
Early Use of TIPS With Polytetrafluoroethylene(PTFE) Covered Stents in Cirrhotic Patients With Refractory Ascites
NCT03172273 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Role of Plasma Biomarkers in the Development of Decompensation in Patients With Cirrhosis .
NCT03084185 ·Status: UNKNOWN
-
Improving Performance of Paracentesis in Medical Residency Training
NCT01403987 ·Status: COMPLETED ·Phase: NA